Speaker: Professor Peter Hoffmann, Strand Leader and Lloyd Sansom Chair, Biomaterials Engineering and Nanomedicine, Future Industries Institute, University of South Australia
Title: Advances in clinical proteomics: applications to cancer research
Chair: Dr John Licari, Postdoctoral Research Fellow, Breast Cancer Research Unit, University of Adelaide and BHI, TQEH
Speaker biography: Professor Hoffmann received his PhD in Analytical Chemistry at the University of the Saarland, Germany in 1999. He spent four years in Melbourne working with Professor Richard Simpson and Professor Bruce Kemp where he specialised in the use of free-flow electrophoresis in proteomics and the detection of protein phosphorylation by mass spectrometry. He moved back to Germany in 2003 and played an integral role in establishing a proteomics facility at the University Leipzig, Germany. In 2005, he was recruited back to Australia to establish a Proteomics Centre at the University of Adelaide and held a Chair in Proteomics and was Director of the Adelaide Proteomics Centre at the University of Adelaide. His research is focused on biomarker discovery in cancer, detection of protein phosphorylation and Tissue Imaging Mass Spectrometry. The Adelaide Proteomics Centre housed the national facility for Tissue Imaging Mass Spectrometry for Australia. Professor Hoffmann was also Deputy Director of Institute of Photonics and Advanced Sensing, one of the five research institutes at the University of Adelaide. Professor Hoffmann is currently the Strand Leader and Lloyd Sansom Chair of Biomaterials Engineering and Nanomedicine at the Future Industries Institute at the University of South Australia. Professor Hoffmann is also an elected member of the HUPO Council and was Treasurer of the HUPO executive committee (2017-2019). Professor Hoffmann has published over 100 peer reviewed journal articles and is the President of the Australasian Proteomics Society and the conference Chair of the Lorne Proteomics Symposium and chaired the international HUPO 2019 conference in Adelaide. Professor Hoffmann is also Director of the national NCRIS facility for Tissue Imaging Mass Spectrometry based at the Future Industries Institute at the University of South Australia.
Zoom link: https://adelaide.zoom.us/j/94314943681
Please contact [email protected] for the password.
